Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaMartin Bornhäuser, Marc Schmitz, Hanka Jähnisch et al.|Blood|2011Cited by 50
Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasiaKarin D. Prummel, Borhane Guezguez, Kevin E. Woods et al.|Nature Communications|2025Cited by 15
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trialAnne Sophie Platzbecker, Christian Thiede, Julia Annabell Georgi et al.|Blood|2025Cited by 5
Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression <i>in Vitro</i>Manja Wobus, Katja Sockel, Ekaterina Balaian et al.|Blood|2021Cited by 2
Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDSKarin D. Prummel, Borhane Guezguez, Kevin E. Woods et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0